Robin Care is a technology company.
Robin Care has raised $3.0M across 1 funding round.
Robin Care has raised $3.0M in total across 1 funding round.
Robin Healthcare (also referred to as Robin Health or Robin) is a Berkeley, CA-based technology company developing the Robin Assistant, a hardware device paired with AI software that automates clinical documentation in medical exam rooms. It serves physicians, particularly in complex specialties like orthopedics, by capturing natural doctor-patient dialogues via ambient speech recognition, generating billable SOAP notes, ensuring compliance, and integrating directly into electronic medical records (EMRs), saving doctors an average of 90 minutes per day on administrative tasks.[1][2][3][4] The platform combines machine learning, voice recognition, and human oversight for accuracy, with military-grade encryption and full HIPAA/SOC 2 compliance, solving the burden of paperwork that distracts from patient care while guaranteeing audit protection at little to no net cost.[2][3][4]
Founded by repeat entrepreneurs, Robin emerged from stealth in 2021 with strong growth, raising a $50M Series B led by Scale Venture Partners, achieving 300% compounded annual growth, and focusing initially on mid-sized practices to refine its AI before expanding specialties.[2][4]
Robin Healthcare was founded by a team of repeat entrepreneurs, including CEO Noah Auerhahn, who previously built and sold Extrabux (San Diego's fourth-fastest-growing company, acquired by Ebates in 2013), alongside experts with clinical training from UCSF and UCLA, informatics/ML experience from Duke, and NLP from UC Berkeley.[3] The idea stemmed from addressing physicians' top pain point: tedious documentation amid complex insurer, compliance, and liability rules, which rob time from patients.[1][3]
Launching from stealth mode around 2021, Robin quickly gained traction with its unobtrusive exam-room device that drafts fully billable notes without workflow changes, backed by a robust QA process involving trained staff.[3] A pivotal moment came in late 2021 with the $50M Series B from Scale Venture Partners, fueling expansion and validating its human-AI hybrid model amid rising AI healthcare demands.[2][4]
Robin rides the AI-in-healthcare wave, specifically "cognitive applications" blending advanced AI, real-world data, and API interconnectivity to transform enterprise software like EMRs.[4] Timing is ideal amid physician burnout from administrative overload (2+ hours/day on notes), post-pandemic staffing shortages, and value-based care demanding precise billing/compliance.[2][3] Market forces favoring Robin include exploding demand for ambient AI scribes (projected multi-billion market), regulatory pushes for efficiency, and investor enthusiasm for hybrid models that outperform standalone AI in regulated fields.[2][4]
It influences the ecosystem by standardizing clinical data for better reporting/billing, enabling physician autonomy, and paving the way for AI expansion into care coordination—positioning as a leader in human-centered healthcare tech.[1][3]
Robin is primed to dominate clinical documentation, expanding from orthopedics to all specialties with refined AI, larger practices, and potential new features like advanced analytics.[4] Trends like generative AI maturation, telehealth integration, and global clinician shortages will accelerate adoption, while partnerships (e.g., with EMR giants) could boost scale. Its influence may evolve into a full care platform, making "paperwork-free" medicine standard and rehumanizing doctor-patient interactions, fulfilling its promise to empower physicians at the heart of healthcare.[2][3]
Robin Care has raised $3.0M in total across 1 funding round.
Robin Care's investors include 7percent Ventures, Accel, Acequia Capital, Andreessen Horowitz, Anorak Ventures, Audrey Capital, Bain Capital Credit, Coatue, Founder Collective, Freestyle Capital, LAUNCH, Liquid 2 Ventures.
Robin Care has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Venture Round in November 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2017 | $3.0M Venture Round | 7percent Ventures, Accel, Acequia Capital, Andreessen Horowitz, Anorak Ventures, Audrey Capital, Bain Capital Credit, Coatue, Founder Collective, Freestyle Capital, LAUNCH, Liquid 2 Ventures, Matrix, Pathbreaker Ventures, Susa Ventures, Uncork Capital, UpHonest Capital, Zinc, Gautam Shah, John Collison, Louis Beryl, Matt Mazzeo, Samvit Ramadurgam |